Portal de Periódicos da CAPES

The CD94/NKG2C-Expressing NK Cell Subset Is Augmented in Chronic Lymphocytic Leukemia Patients with Positive Human Cytomegalovirus Serostatus

2009; Mary Ann Liebert, Inc.; Volume: 22; Issue: 5 Linguagem: Inglês

10.1089/vim.2009.0032

1557-8976

Line Petersen, Anne Stidsholt Roug, Anni Skovbo, Anna Hammerich Thysen, Christian Winther Eskelund, Marianne Hokland,

Viral-associated cancers and disorders

Human cytomegalovirus (HCMV) manipulates the host immune system in various ways. Allegedly, HCMV infection is associated with increased percentages of a particular natural killer (NK) cell subset expressing the activating receptor CD94/NKG2C in both healthy individuals and in patients infected with human immunodeficiency virus (HIV). Whether the HCMV-mediated induction of this specific NK cell subset is also apparent for other diseases characterized by abnormal immune responses, such as malignant blood diseases, is unknown. By comparing the fractions of CD94/NKG2C+ NK cells in B-cell chronic lymphocytic leukemia (B-CLL) patients having either positive or negative HCMV serostatus, a proportional increase of this cell subset was obvious in the HCMV-seropositive subjects. Therapeutic intervention in the patients with positive HCMV serostatus did not seem to reduce the percentage of CD94/NKG2C-expressing NK cells. Thus, HCMV infection seemingly shapes the NK cell system in healthy individuals, HIV patients, and B-CLL patients in a uniform manner, even though these involve different immunological challenges.